AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

NantHealth to Report 2019 First-Quarter Financial Results and Host Conference Call on Thursday, May 9

May 2, 2019

CULVER CITY, Calif.--(BUSINESS WIRE)--May 2, 2019--NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 first quarter on Thursday, May 9, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.

The conference call will be available to interested parties by dialing 844-309-3709 from the U.S. or Canada, or 281-962-4864 from international locations, passcode 6159197. The call will be broadcast via the Internet at www.nanthealth.com.

About NantHealth, Inc.

NantHealth, a member of the NantWorks ecosystem of companies, provides leading solutions across the continuum of care for physicians, payors, patients and biopharmaceutical organizations. NantHealth enables the use of cutting edge data and technology towards the goals of empowering clinical decision support and improving patient outcomes. NantHealth’s comprehensive product portfolio combines the latest technology in molecular analysis (GPS Cancer ® and Liquid GPS ® ), payor/provider platforms that exchange information in near-real time (NaviNet and Eviti), and connected care solutions that deliver Medical Device Interoperability (MDI). NantHealth’s GPS Cancer ® molecular profiling provides comprehensive DNA & RNA tumor-normal profiling combined with pharmacogenomics analysis. Liquid GPS ® provides non-invasive testing of cfDNA and cfRNA to monitor cancer mutations and potentially select targeted therapies, chemotherapies, and immunotherapies. For more information, please visit www.nanthealth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190502005254/en/

CONTACT: Investor Contact:

Robert Jaffe

424.288.4098

rjaffe@rjaffeco.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT SOFTWARE PRACTICE MANAGEMENT HEALTH BIOTECHNOLOGY GENETICS MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES FINANCE

SOURCE: NantHealth, Inc.

Copyright Business Wire 2019.

PUB: 05/02/2019 06:54 AM/DISC: 05/02/2019 06:54 AM

http://www.businesswire.com/news/home/20190502005254/en